Get started
Author

Yuta Okazaki

Observed names: Y. Okazaki, YUTA OKAZAKI
ORCID: 0009-0007-4599-8897
Observed ORCID: 0009-0007-4599-8897
OpenAlex ID: A5102653014
Exploration of clinical Biomarkers for guiding treatment selection between chemotherapy and combination therapy with Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Mutant NSCLC patients after EGFR-TKI Therapy: The SPIRAL-STEP study
2025 · Kenji Morimoto, Tadaaki Yamada, et al. · Lung Cancer · 10
PDF
Efficacy and Safety Evaluation of Immune Checkpoint Inhibitors in Combination With Chemotherapy for Extensive Small Cell Lung Cancer: Real‐World Evidence
2024 · Yuta Yamanaka, Yukiko Okuno, et al. · Cancer Medicine · 6
PDF
Impact of time to treatment initiation on the development of cachexia and clinical outcomes in lung cancer
2025 · Utae Katsushima, Satoshi Kurose, et al. · Japanese Journal of Clinical Oncology · 4
Investigation of a practical assessment index to capture the clinical presentation of cachexia in patients with lung cancer
2024 · Utae Katsushima, Kimitaka Hase, et al. · Japanese Journal of Clinical Oncology · 3
Impact of EGFR Mutation Subtypes on Response to Chemoimmunotherapy and Chemotherapy in Non-Small-Cell Lung Cancer After EGFR-TKI Failure
2025 · Kenji Morimoto, Tadaaki Yamada, et al. · Targeted Oncology · 2
Comparative Study on Associations Between Lung Cancer Prognosis and Diagnostic Criteria Set by the European Palliative Care Research Collaboration and the Asian Working Group for Cachexia
2024 · Utae Katsushima, Takuya Fukushima, et al. · Thoracic Cancer · 2
PDF
A Case of Radiation Recall Pneumonitis Caused by Nivolumab+Ipilimumab Combination Therapy
2023 · Yume Ikeda, Hiroshige Yoshioka, et al. · Haigan · 2
AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer
2026 · Tatsuki Ikoma, Keigo Araki, et al. · Molecular Therapy Oncology · 1
Chronic pulmonary aspergillosis complicated by a lung abscess within a pulmonary cavity successfully treated with percutaneous drainage: A case report
2026 · Yuta Okazaki, Masahiro Shirata, et al. · Internal Medicine · 1
PDF
Real-world treatment outcomes before and after chemoimmunotherapy approval in EGFR-mutant NSCLC after EGFR-TKI failure: a Japanese cohort study
2025 · Kenji Morimoto, Tadaaki Yamada, et al. · International Journal of Clinical Oncology · 1
Should supportive care be started before initiating cancer treatment?
2026 · Utae Katsushima, Eisuke Ochi, et al. · Supportive Care in Cancer
Cancer Cachexia Predicts Benefit of Immunotherapy Plus Chemotherapy in EGFR -mutant NSCLC After TKI Resistance
2026 · HARUKA NAKATANI, HAYATO KAWACHI, et al. · Anticancer Research
Clinical trajectory of KRAS G12C-mutated advanced non-small cell lung cancer: a single-center cohort study in Japan
2026 · Yuta Okazaki, Hiroshige Yoshioka, et al. · Respiratory Investigation
Abstract 5238: Retrospective study for clinical biomarkers to guide post-EGFR-TKI treatment strategies in EGFR-mutant NSCLC
2026 · Tadaaki Yamada, Kenji Morimoto, et al. · Cancer Research
"Chronic Pulmonary Aspergillosis Complicated by a Lung Abscess Within a Pulmonary Cavity Successfully Treated With Percutaneous Drainage: A Case Report"
2026 · Yuta Okazaki, Masahiro Shirata, et al. · Internal Medicine
PDF
1013P Impact of chemoimmunotherapy approval on post-EGFR-TKI treatment outcomes in EGFR-mutant NSCLC: Insights from a real-world Japanese cohort
2025 · T. Yamada, K. Morimoto, et al. · Annals of Oncology
1064P Evaluation of platinum-free interval to re-administration of platinum-based chemotherapy for recurrent small cell lung cancer in the era of chemoimmunotherapy
2025 · Y. Okazaki, H. Yoshioka, et al. · Annals of Oncology
Analysis of Poor Prognostic Factors and Treatment Strategies in Platinum-Based Systemic Therapy After EGFR-TKI Failure in Patients With Advanced Nonsmall Cell Lung Cancer Harboring EGFR Mutations
2025 · Tae Hata, Tadaaki Yamada, et al. · Clinical Lung Cancer
The impacts on prognosis of the relationship between decline in renal function associated with pemetrexed and the ratio of pemetrexed administration.
2025 · Yuta Yamanaka, Kenta Murotani, et al. · Journal of Clinical Oncology
Paraneoplastic Neurological Syndrome-associated Antibody-positive Small-cell Lung Cancer Diagnosed with Preceding Neurological Symptoms: a Case Series
2024 · Yuta Okazaki, Hiroshige Yoshioka, et al. · Haigan
PDF
Works count: 20
Citation count: 32
H-index: 3
I10-index: 1
Year
Topic
Type